Browse drugs

…t common limitation (110 trials, 55.3%). Compared with placebo, calcium channel blockers (mean difference (MD) −1.78 (95% CI −2.96 to −0.60), moderate c…

…to mid 2000s. These trends, alongside decreasing use of several antihypertensive drugs and in the context of worsening population level control, may r…

…blockers, amiodarone, flecainide, calcium channel blockers, and digoxin, which are commonly prescribed for rhythm management in these p…

…in SSc patients with a reduced eGFR at baseline. Treatment with calcium channel blockers (p<0.0001) and immunosuppressors (p<0.01) was more frequent in …

… and the thyroid disease guideline37 advises “Consider starting levothyroxine at a dosage of 25 to 50 micrograms per day with titration for a…

…tients, reduced recurrence risk was associated only with use of calcium channel blockers (adjusted HR (aHR) 0.91, 95% CI 0.86 to 0.97), thiazide diureti…

…subarachnoid hemorrhage, cerebral infarction), and medications (beta blockers, calcium channel blockers, antiarrhythmics, antilipemic agents,…

…dney disease. Although angiotensin receptor blockers (ARBs) and calcium channel blockers (CCBs) are widely used antihypertensive agents in CKD, comparat…

…esterase inhibitors were excluded. Other vasoactive treatments (calcium channel blockers) were stopped two days before the experiments. Forty-two female…

… anti-acids (proton pump inhibitors, H2 blockers), antibiotics, calcium channel blockers, NSAIDs and pain killers. No significant differences between SS…

… among the GLP-1RA group compared with the sulfonylureas group. GLP-1RA=glucagon-like peptide-1 receptor agonistsDiscussionIn this nati…

… p=0.001), and more targeted antianginal prescribing, including calcium channel blockers (43.5% vs 27.0%; p=0.008) and long-acting nitrates (56.5% vs 32…